Lonza: Pierre-Alain Ruffieux
Pierre-Alain Ruffieux starts his role as Lonza’s Chief Executive Officer this week, following his appointment in June.
Pierre-Alain brings with him more than 20 years of experience in biopharmaceuticals, most recently as Head of Global Pharma Technical Operations at Roche, where he oversaw pharmaceutical commercial manufacturing and supply chain operations. Before joining Roche in 2015, he spent 12 years with Novartis. He holds a Masters' degree in Chemical Engineering and a Ph.D. in Biotechnology, both from The Swiss Institute of Technology in Lausanne (EPFL).
Pierre-Alain joins Lonza “at a significant moment of opportunity”, with the company noting increased global awareness of the critical industry contribution made by pharma and biotech manufacturing technologies. The Swiss company generated sales of CHF 5.9bn ($6.5bn) in 2019 and has 15,500 full time employees.
Meanwhile, Albert M. Baehny resumes his role as Chairman of the Board of Directors, after a year in the role of Chief Executive Officer ad interim.
